SLC16A5 and cancer: Our analysis revealed nine differentially expressed MCT genes in both stromal and epithelial samples, including the upregulated thyroid hormone (TH) transporters MCT8 (SLC16A12) and MCT10 (SLC16A10), monocarboxylate transporter MCT2 (SLC16A7), MCT6 (SLC16A5) with a potential role in glucose and lipid metabolism, and an lncRNA SLC16A1-AS1 previously identified as a prognostic or diagnostic biomarker in a number of cancers [20,54,55,56,57,58,59,60,61].